|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 225 for Abcb4

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.054s

Categories

Category: Publication
« show all
Type Details Score
Publication
23545228 | J:199949
First Author: Hochrath K
Year: 2013
Journal: Bone
Title: Modeling hepatic osteodystrophy in Abcb4 deficient mice.
Volume: 55
Issue: 2
Pages: 501-11
•
•
•
•
•
Publication
22982378 | J:193578
First Author: Hochrath K
Year: 2012
Journal: FASEB J
Title: The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis.
Volume: 26
Issue: 12
Pages: 5081-91
•
•
•
•
•
Publication
3405218 | J:9293
First Author: Gros P
Year: 1988
Journal: Mol Cell Biol
Title: Cloning and characterization of a second member of the mouse mdr gene family.
Volume: 8
Issue: 7
Pages: 2770-8
•
•
•
•
•
Publication
1990275 | J:224749
First Author: Buschman E
Year: 1991
Journal: Mol Cell Biol
Title: Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes.
Volume: 11
Issue: 2
Pages: 595-603
•
•
•
•
•
Publication
1381362 | J:2241
First Author: Buschman E
Year: 1992
Journal: J Biol Chem
Title: mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies.
Volume: 267
Issue: 25
Pages: 18093-9
•
•
•
•
•
Publication
8106172 | J:15531
First Author: Smit JJ
Year: 1993
Journal: Cell
Title: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.
Volume: 75
Issue: 3
Pages: 451-62
•
•
•
•
•
Publication
7912658 | J:18957
First Author: Ruetz S
Year: 1994
Journal: Cell
Title: Phosphatidylcholine translocase: a physiological role for the mdr2 gene.
Volume: 77
Issue: 7
Pages: 1071-81
•
•
•
•
•
Publication
8615769 | J:32078
 
First Author: Chianale J
Year: 1996
Journal: Biochem J
Title: Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.
Volume: 314 ( Pt 3)
Pages: 781-6
•
•
•
•
•
Publication
8725158 | J:33251
First Author: Oude Elferink RP
Year: 1996
Journal: J Lipid Res
Title: Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein.
Volume: 37
Issue: 5
Pages: 1065-75
•
•
•
•
•
Publication
33418034 | J:321048
First Author: Gonzalez-Sanchez E
Year: 2021
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice.
Volume: 1867
Issue: 4
Pages: 166067
•
•
•
•
•
Publication
2471060 | J:9805
First Author: Croop JM
Year: 1989
Journal: Mol Cell Biol
Title: The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues.
Volume: 9
Issue: 3
Pages: 1346-50
•
•
•
•
•
Publication
1969609 | J:10390
First Author: Raymond M
Year: 1990
Journal: Mol Cell Biol
Title: Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells.
Volume: 10
Issue: 4
Pages: 1642-51
•
•
•
•
•
Publication
7814632 | J:22312
First Author: Oude Elferink RP
Year: 1995
Journal: J Clin Invest
Title: Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.
Volume: 95
Issue: 1
Pages: 31-8
•
•
•
•
•
Publication
32846954 | J:313527
 
First Author: Hahn L
Year: 2020
Journal: Cells
Title: IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice.
Volume: 9
Issue: 9
•
•
•
•
•
Publication
23468132 | -
First Author: Morita SY
Year: 2013
Journal: J Lipid Res
Title: Bile salt-stimulated phospholipid efflux mediated by ABCB4 localized in nonraft membranes.
Volume: 54
Issue: 5
Pages: 1221-30
•
•
•
•
•
Publication
31836711 | J:336876
First Author: Weber ND
Year: 2019
Journal: Nat Commun
Title: Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.
Volume: 10
Issue: 1
Pages: 5694
•
•
•
•
•
Publication
15930516 | J:100491
First Author: Langheim S
Year: 2005
Journal: J Lipid Res
Title: ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile.
Volume: 46
Issue: 8
Pages: 1732-8
•
•
•
•
•
Publication
28184004 | J:241375
First Author: O'Hara SP
Year: 2017
Journal: J Biol Chem
Title: ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A.
Volume: 292
Issue: 12
Pages: 4833-4846
•
•
•
•
•
Publication
14752830 | J:105357
First Author: Lammert F
Year: 2004
Journal: Hepatology
Title: Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.
Volume: 39
Issue: 1
Pages: 117-28
•
•
•
•
•
Publication
31176036 | J:279670
First Author: Ikeda Y
Year: 2019
Journal: Biochim Biophys Acta Mol Cell Biol Lipids
Title: Enhancing effect of taurohyodeoxycholate on ABCB4-mediated phospholipid efflux.
Volume: 1864
Issue: 10
Pages: 1495-1502
•
•
•
•
•
Publication
24481602 | J:210186
First Author: Cai SY
Year: 2014
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.
Volume: 306
Issue: 8
Pages: G670-6
•
•
•
•
•
Publication
30897344 | J:290915
First Author: Potikha T
Year: 2019
Journal: FASEB J
Title: Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
Volume: 33
Issue: 7
Pages: 7995-8007
•
•
•
•
•
Publication
29572910 | J:323091
First Author: Slijepcevic D
Year: 2018
Journal: Hepatology
Title: Na+ -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice.
Volume: 68
Issue: 3
Pages: 1057-1069
•
•
•
•
•
Publication
28894223 | J:255559
First Author: Cariello M
Year: 2017
Journal: Sci Rep
Title: Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice.
Volume: 7
Issue: 1
Pages: 11203
•
•
•
•
•
Publication
27995969 | J:253823
 
First Author: Petruzzelli M
Year: 2016
Journal: Sci Rep
Title: Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice.
Volume: 6
Pages: 39278
•
•
•
•
•
Publication
32612285 | J:328951
First Author: Irungbam K
Year: 2020
Journal: Lab Invest
Title: Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice.
Volume: 100
Issue: 11
Pages: 1411-1424
•
•
•
•
•
Publication
27391331 | J:252474
First Author: Weber SN
Year: 2016
Journal: PLoS One
Title: TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Volume: 11
Issue: 7
Pages: e0158819
•
•
•
•
•
Publication
24264436 | J:205330
 
First Author: Mederacke I
Year: 2013
Journal: Nat Commun
Title: Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.
Volume: 4
Pages: 2823
•
•
•
•
•
Publication
29941600 | J:263853
First Author: Pacella I
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth.
Volume: 115
Issue: 28
Pages: E6546-E6555
•
•
•
•
•
Publication
33093654 | J:301427
First Author: Gamaev L
Year: 2021
Journal: Oncogene
Title: The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
Volume: 40
Issue: 1
Pages: 127-139
•
•
•
•
•
Publication
16384875 | J:111087
First Author: Werner A
Year: 2006
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Lymphatic chylomicron size is inversely related to biliary phospholipid secretion in mice.
Volume: 290
Issue: 6
Pages: G1177-85
•
•
•
•
•
Publication
27351144 | J:312604
First Author: Jones H
Year: 2016
Journal: Hepatology
Title: Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.
Volume: 64
Issue: 4
Pages: 1202-1216
•
•
•
•
•
Publication
23540693 | J:197248
First Author: Shukla R
Year: 2013
Journal: Cell
Title: Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma.
Volume: 153
Issue: 1
Pages: 101-11
•
•
•
•
•
Publication
12223350 | J:108285
First Author: Werner A
Year: 2002
Journal: Am J Physiol Gastrointest Liver Physiol
Title: Fat malabsorption in essential fatty acid-deficient mice is not due to impaired bile formation.
Volume: 283
Issue: 4
Pages: G900-8
•
•
•
•
•
Publication
29734330 | J:263233
First Author: Collino A
Year: 2018
Journal: PLoS Genet
Title: Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage.
Volume: 14
Issue: 5
Pages: e1007380
•
•
•
•
•
Publication
20921947 | J:168123
First Author: Strack I
Year: 2011
Journal: Lab Invest
Title: β-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis.
Volume: 91
Issue: 2
Pages: 252-61
•
•
•
•
•
Publication
28634212 | J:253394
First Author: Wu N
Year: 2017
Journal: FASEB J
Title: Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
Volume: 31
Issue: 10
Pages: 4305-4324
•
•
•
•
•
Publication
16618719 | J:108307
First Author: Katzenellenbogen M
Year: 2006
Journal: Cancer Res
Title: Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
Volume: 66
Issue: 8
Pages: 4001-10
•
•
•
•
•
Publication
35271760 | J:338999
First Author: O'Brien A
Year: 2022
Journal: Hepatol Commun
Title: FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2(-/-) Mouse Model of Primary Sclerosing Cholangitis.
Volume: 6
Issue: 7
Pages: 1574-1588
•
•
•
•
•
Publication
10526224 | J:114159
First Author: Minich DM
Year: 1999
Journal: Biochim Biophys Acta
Title: Biliary phospholipid secretion is not required for intestinal absorption and plasma status of linoleic acid in mice.
Volume: 1441
Issue: 1
Pages: 14-22
•
•
•
•
•
Publication
8698195 | J:34646
First Author: Van Nieuwkerk CM
Year: 1996
Journal: Gastroenterology
Title: Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene.
Volume: 111
Issue: 1
Pages: 165-71
•
•
•
•
•
Publication
34896073 | J:327761
First Author: Petrescu AD
Year: 2022
Journal: Am J Pathol
Title: Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis.
Volume: 192
Issue: 3
Pages: 484-502
•
•
•
•
•
Publication
15910498 | J:110130
First Author: Hulzebos CV
Year: 2005
Journal: Liver Int
Title: Bile duct proliferation associated with bile salt-induced hypercholeresis in Mdr2 P-glycoprotein-deficient mice.
Volume: 25
Issue: 3
Pages: 604-12
•
•
•
•
•
Publication
23102701 | J:194005
First Author: Singer S
Year: 2012
Journal: Mol Cell
Title: Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.
Volume: 48
Issue: 5
Pages: 799-810
•
•
•
•
•
Publication
16223543 | J:333339
First Author: Popov Y
Year: 2005
Journal: J Hepatol
Title: Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes.
Volume: 43
Issue: 6
Pages: 1045-54
•
•
•
•
•
Publication
17431106 | J:133445
First Author: Katzenellenbogen M
Year: 2007
Journal: Mol Cancer Ther
Title: Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice.
Volume: 6
Issue: 4
Pages: 1283-91
•
•
•
•
•
Publication
16715553 | J:97853
First Author: Mann DA
Year: 2005
Journal: J Hepatol
Title: NF-kappaB: a signal for cancer.
Volume: 42
Issue: 4
Pages: 610-1
•
•
•
•
•
Publication
15329734 | J:92668
First Author: Pikarsky E
Year: 2004
Journal: Nature
Title: NF-kappaB functions as a tumour promoter in inflammation-associated cancer.
Volume: 431
Issue: 7007
Pages: 461-6
•
•
•
•
•
Publication
9696021 | J:50317
First Author: Smith AJ
Year: 1998
Journal: Hepatology
Title: Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice.
Volume: 28
Issue: 2
Pages: 530-6
•
•
•
•
•
Publication
37059338 | J:336161
First Author: Kang JH
Year: 2023
Journal: Gastroenterology
Title: The Epigenetic Reader, Bromodomain Containing 2, Mediates Cholangiocyte Senescence via Interaction With ETS Proto-Oncogene 1.
Volume: 165
Issue: 1
Pages: 228-243.e2
•
•
•
•
•
Publication
28502477 | J:243581
First Author: Kyritsi K
Year: 2017
Journal: Am J Pathol
Title: Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.
Volume: 187
Issue: 7
Pages: 1551-1565
•
•
•
•
•
Publication
11113093 | J:66180
First Author: De Vree JM
Year: 2000
Journal: Gastroenterology
Title: Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis.
Volume: 119
Issue: 6
Pages: 1720-30
•
•
•
•
•
Publication
31832573 | J:286449
First Author: Rajapaksha IG
Year: 2019
Journal: Hepatol Commun
Title: Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout Mice.
Volume: 3
Issue: 12
Pages: 1656-1673
•
•
•
•
•
Publication
9148004 | J:39046
First Author: van Nieuwerk CM
Year: 1997
Journal: J Hepatol
Title: The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females.
Volume: 26
Issue: 1
Pages: 138-45
•
•
•
•
•
Publication
30890428 | J:275550
First Author: Chen L
Year: 2019
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.
Volume: 1865
Issue: 6
Pages: 1525-1539
•
•
•
•
•
Publication
36304458 | J:333894
 
First Author: Habenicht LKL
Year: 2022
Journal: Front Immunol
Title: The C1q-ApoE complex: A new hallmark pathology of viral hepatitis and nonalcoholic fatty liver disease.
Volume: 13
Pages: 970938
•
•
•
•
•
Publication
21912653 | J:177702
First Author: Philips GM
Year: 2011
Journal: PLoS One
Title: Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.
Volume: 6
Issue: 9
Pages: e23943
•
•
•
•
•
Publication
30914432 | J:276357
First Author: Malakar P
Year: 2019
Journal: Cancer Res
Title: Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2.
Volume: 79
Issue: 10
Pages: 2480-2493
•
•
•
•
•
Publication
24687604 | J:213424
First Author: Horwitz E
Year: 2014
Journal: Cancer Discov
Title: Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.
Volume: 4
Issue: 6
Pages: 730-43
•
•
•
•
•
Publication
7977654 | J:21232
First Author: Mauad TH
Year: 1994
Journal: Am J Pathol
Title: Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.
Volume: 145
Issue: 5
Pages: 1237-45
•
•
•
•
•
Publication
15633131 | J:95371
First Author: Kruit JK
Year: 2005
Journal: Gastroenterology
Title: Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice.
Volume: 128
Issue: 1
Pages: 147-56
•
•
•
•
•
Publication
23707514 | J:202509
First Author: Sokolović A
Year: 2013
Journal: Biochim Biophys Acta
Title: Fasting reduces liver fibrosis in a mouse model for chronic cholangiopathies.
Volume: 1832
Issue: 10
Pages: 1482-91
•
•
•
•
•
Publication
10611166 | J:59783
First Author: Voshol PJ
Year: 2000
Journal: Gastroenterology
Title: Postprandial chylomicron formation and fat absorption in multidrug resistance gene 2 P-glycoprotein-deficient mice.
Volume: 118
Issue: 1
Pages: 173-82
•
•
•
•
•
Publication
16472600 | J:326170
First Author: Fickert P
Year: 2006
Journal: Gastroenterology
Title: 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Volume: 130
Issue: 2
Pages: 465-81
•
•
•
•
•
Publication
35863741 | J:327910
     
First Author: Ceci L
Year: 2022
Journal: Cell Mol Gastroenterol Hepatol
Title: Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model.
•
•
•
•
•
Publication
15236191 | J:93576
First Author: Fickert P
Year: 2004
Journal: Gastroenterology
Title: Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Volume: 127
Issue: 1
Pages: 261-74
•
•
•
•
•
Publication
30389969 | J:268219
First Author: Barikbin R
Year: 2018
Journal: Sci Rep
Title: Early heme oxygenase 1 induction delays tumour initiation and enhances DNA damage repair in liver macrophages of Mdr2-/- mice.
Volume: 8
Issue: 1
Pages: 16238
•
•
•
•
•
Publication
29125588 | J:273918
 
First Author: Petrescu AD
Year: 2017
Journal: Int J Mol Sci
Title: Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model.
Volume: 18
Issue: 11
•
•
•
•
•
Publication
18025261 | J:131750
First Author: Katzenellenbogen M
Year: 2007
Journal: Mol Cancer Res
Title: Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Volume: 5
Issue: 11
Pages: 1159-70
•
•
•
•
•
Publication
9558293 | J:47805
First Author: Voshol PJ
Year: 1998
Journal: Gastroenterology
Title: Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice.
Volume: 114
Issue: 5
Pages: 1024-34
•
•
•
•
•
Publication
20133864 | J:157530
First Author: Barash H
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks.
Volume: 107
Issue: 5
Pages: 2207-12
•
•
•
•
•
Publication
7498666 | J:30489
First Author: Groen AK
Year: 1995
Journal: Gastroenterology
Title: Regulation of protein secretion into bile: studies in mice with a disrupted mdr2 p-glycoprotein gene.
Volume: 109
Issue: 6
Pages: 1997-2006
•
•
•
•
•
Publication
33238629 | J:304906
 
First Author: Angioni R
Year: 2020
Journal: Int J Mol Sci
Title: Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice.
Volume: 21
Issue: 22
•
•
•
•
•
Publication
24819516 | J:226213
 
First Author: Iannelli F
Year: 2014
Journal: Nat Commun
Title: Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency.
Volume: 5
Pages: 3850
•
•
•
•
•
Publication
19340302 | J:148175
First Author: Klopstock N
Year: 2009
Journal: PLoS One
Title: HCV tumor promoting effect is dependent on host genetic background.
Volume: 4
Issue: 4
Pages: e5025
•
•
•
•
•
Publication
25478810 | J:217802
First Author: Ikenaga N
Year: 2015
Journal: Am J Pathol
Title: A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.
Volume: 185
Issue: 2
Pages: 325-34
•
•
•
•
•
Publication
28390947 | J:336823
First Author: Gonzalez-Sanchez E
Year: 2017
Journal: Biochim Biophys Acta Mol Basis Dis
Title: Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis.
Volume: 1863
Issue: 7
Pages: 1699-1708
•
•
•
•
•
Publication
8102093 | J:14026
First Author: Zhao JY
Year: 1993
Journal: Endocrinology
Title: Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Volume: 133
Issue: 2
Pages: 521-8
•
•
•
•
•
Publication
7915194 | J:20175
First Author: Buschman E
Year: 1994
Journal: Cancer Res
Title: The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein.
Volume: 54
Issue: 18
Pages: 4892-8
•
•
•
•
•
Publication
7857397 | J:21999
First Author: Higgins CF
Year: 1994
Journal: Curr Biol
Title: P-glycoprotein. To flip or not to flip?
Volume: 4
Issue: 3
Pages: 259-60
•
•
•
•
•
Publication
7558881 | J:28982
First Author: Wettergren Y
Year: 1995
Journal: Hereditas
Title: Colcemid resistance in murine SEWA cells: non-Pgy gene amplification at low levels of resistance and preferential Pgy2 gene amplification at high levels of resistance.
Volume: 122
Issue: 2
Pages: 125-34
•
•
•
•
•
Publication
8679007 | J:34793
First Author: Zimonjic DB
Year: 1996
Journal: Mamm Genome
Title: Localization of rat Pgy3 (mdr2) to the same region as Pgy2 (mdr1b) at 4q11-12.
Volume: 7
Issue: 8
Pages: 630-1
•
•
•
•
•
Publication
9034162 | J:38217
First Author: Elferink RP
Year: 1997
Journal: FASEB J
Title: Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport.
Volume: 11
Issue: 1
Pages: 19-28
•
•
•
•
•
Publication
23588707 | J:198835
First Author: Tabibian JH
Year: 2013
Journal: Lab Invest
Title: Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography.
Volume: 93
Issue: 6
Pages: 733-43
•
•
•
•
•
Publication
31940841 | J:304487
 
First Author: Li X
Year: 2020
Journal: Cells
Title: Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions.
Volume: 9
Issue: 1
•
•
•
•
•
Publication
30985008 | J:327322
First Author: Liu R
Year: 2019
Journal: Hepatology
Title: Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
Volume: 70
Issue: 4
Pages: 1317-1335
•
•
•
•
•
Publication
36483737 | J:331995
 
First Author: Hu Y
Year: 2022
Journal: Front Pharmacol
Title: Gypenosides ameliorate ductular reaction and liver fibrosis via inhibition of hedgehog signaling.
Volume: 13
Pages: 1033103
•
•
•
•
•
Publication
32054995 | J:296995
First Author: Kennedy L
Year: 2020
Journal: Lab Invest
Title: Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.
Volume: 100
Issue: 6
Pages: 837-848
•
•
•
•
•
Publication
25331529 | J:221390
First Author: De Ponti A
Year: 2015
Journal: Int J Cancer
Title: Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9.
Volume: 136
Issue: 10
Pages: 2458-63
•
•
•
•
•
Publication
29404503 | J:282053
First Author: Peng ZW
Year: 2017
Journal: Hepatol Commun
Title: The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.
Volume: 1
Issue: 9
Pages: 957-972
•
•
•
•
•
Publication
30416103 | J:269096
First Author: Wang R
Year: 2019
Journal: J Lipid Res
Title: Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2-/- mice.
Volume: 60
Issue: 1
Pages: 85-97
•
•
•
•
•
Publication
35691019 | J:335005
First Author: Fuchs CD
Year: 2022
Journal: Hepatol Commun
Title: Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2(-/-) mouse model of sclerosing cholangitis via immunomodulatory effects.
Volume: 6
Issue: 9
Pages: 2368-2378
•
•
•
•
•
Publication
16144842 | J:102893
First Author: Li Z
Year: 2005
Journal: J Biol Chem
Title: Phosphatidylcholine homeostasis and liver failure.
Volume: 280
Issue: 45
Pages: 37798-802
•
•
•
•
•
Publication
16679290 | J:129649
First Author: Li Z
Year: 2006
Journal: Cell Metab
Title: The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
Volume: 3
Issue: 5
Pages: 321-31
•
•
•
•
•
Publication
21292027 | J:175015
First Author: Li Z
Year: 2011
Journal: Biochim Biophys Acta
Title: The role of phosphatidylethanolamine methyltransferase in a mouse model of intrahepatic cholestasis.
Volume: 1811
Issue: 4
Pages: 278-83
•
•
•
•
•
Publication
17283071 | J:121149
First Author: Li Z
Year: 2007
Journal: J Biol Chem
Title: Choline redistribution during adaptation to choline deprivation.
Volume: 282
Issue: 14
Pages: 10283-9
•
•
•
•
•
Publication
23423643 | J:298389
First Author: Potikha T
Year: 2013
Journal: Hepatology
Title: Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
Volume: 58
Issue: 1
Pages: 192-204
•
•
•
•
•
Publication
17854600 | J:128386
First Author: van der Velde AE
Year: 2007
Journal: Gastroenterology
Title: Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice.
Volume: 133
Issue: 3
Pages: 967-75
•
•
•
•
•
Publication
11368757 | J:114411
First Author: Voshol PJ
Year: 2001
Journal: Biochem J
Title: Down-regulation of intestinal scavenger receptor class B, type I (SR-BI) expression in rodents under conditions of deficient bile delivery to the intestine.
Volume: 356
Issue: Pt 2
Pages: 317-25
•
•
•
•
•
Publication
31362006 | J:278032
     
First Author: Fan W
Year: 2019
Journal: Gastroenterology
Title: ECM1 Prevents Activation of Transforming Growth Factor beta, Hepatic Stellate Cells, and Fibrogenesis in Mice.
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom